Pfizer headquarters in New York. Getty Images Pfizer and Germany’s BioNTech announced on Wednesday that they would develop a potential mRNA-based vaccine for the prevention of viral shingles, working together for the third time after the success of their COVID-19 vaccine. Pfizer partnered with BioNTech in 2018 for an influenza vaccine and again in 2020 […]
